- ByReuters-
By Brendan Pierson (Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can...
Last | High | Low | |||||
---|---|---|---|---|---|---|---|
177.61 | 177.90 | 172.21 | +4.86 | +2.81% | 5.75M | ||
162.30 | 162.57 | 158.51 | +4.04 | +2.55% | 10.32M | ||
338.52 | 340.89 | 335.12 | -0.73 | -0.22% | 8.32M | ||
30.85 | 30.96 | 29.94 | +0.69 | +2.29% | 95.67M | ||
415.13 | 416.63 | 404.52 | +0.94 | +0.23% | 28.56M | ||
103.91 | 104.08 | 101.41 | +2.21 | +2.17% | 14.69M | ||
57.63 | 57.75 | 56.59 | +0.95 | +1.68% | 5.87M | ||
46.50 | 46.57 | 46.01 | +0.38 | +0.82% | 39.26M | ||
456.52 | 456.77 | 448.12 | +6.29 | +1.40% | 2.63M | ||
202.63 | 203.30 | 198.35 | +3.30 | +1.66% | 14.4M | ||
62.93 | 63.03 | 61.69 | +0.96 | +1.55% | 19.76M | ||
258.89 | 259.23 | 253.51 | +6.82 | +2.71% | 6.12M | ||
125.54 | 126.61 | 124.55 | +1.01 | +0.81% | 17.9M | ||
100.14 | 100.24 | 97.42 | +1.94 | +1.98% | 21.67M | ||
192.25 | 192.57 | 189.91 | +1.03 | +0.54% | 75M | ||
176.44 | 179.21 | 173.87 | -2.88 | -1.60% | 44.18M | ||
305.85 | 305.90 | 299.55 | +4.85 | +1.61% | 4.26M | ||
65.76 | 65.90 | 64.16 | +0.87 | +1.34% | 27.57M | ||
334.87 | 335.15 | 328.04 | +5.69 | +1.73% | 5.55M | ||
166.85 | 166.97 | 163.84 | +1.22 | +0.74% | 4.9M | ||
41.15 | 41.28 | 40.10 | +0.82 | +2.03% | 37.64M | ||
215.70 | 215.88 | 211.62 | +3.21 | +1.51% | 2.12M | ||
146.67 | 147.48 | 145.24 | +1.39 | +0.96% | 14.35M | ||
240.00 | 240.19 | 235.92 | +2.78 | +1.17% | 5.09M | ||
202.19 | 202.26 | 199.14 | +1.31 | +0.65% | 3.16M | ||
234.44 | 234.62 | 216.09 | +16.43 | +7.54% | 36.74M | ||
272.46 | 272.74 | 269.02 | +1.16 | +0.43% | 8.91M | ||
495.37 | 498.41 | 482.08 | +13.72 | +2.85% | 6.69M | ||
95.05 | 95.07 | 92.97 | +1.60 | +1.71% | 12.54M | ||
164.54 | 164.76 | 161.97 | +1.96 | +1.21% | 10.31M |
By Brendan Pierson (Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can...
According to analysts at Bank of America Securities, a best-case scenario for stocks involves slowing GDP and accelerating earnings growth. In a research note Tuesday, the...
GuruFocus - On May 30, 2024, Gail Marcus, Director at Natera Inc (NASDAQ:NTRA), executed a sale of 2,000 shares of the company at a price of $110.17 per share. This transaction was...
Technology stocks have continue to lead the broader market higher in 2024, posting new high after new high. At the same time, this is the very reason we watch the Nasdaq related...
Over the last five days, the Dow Jones Industrial Average (DJIA) has continued to show weakness, having slumped by -3.99% to present 38,111. This level was last seen at the end of...
In this episode of The Canadian Investor Podcast, we cover a range of earnings reports and investing news. We start by discussing Nvidia (NASDAQ:NVDA)'s phenomenal...